Asia Pacific cassava starch market was valued at US$ 1,965.2 million in 2023 and is projected to hit the market valuation of US$ 3,357.0 million by 2032 at a CAGR of 6.35% during the forecast period ...
Chido Nwangwu in this piece writes about a US-based Nigerian, Dr Patrick Okoye, who gets recognised recently as having the first United States Patent on Cassava Starch in medicines.
Cassava Sciences' Alzheimer's drug simufilam failed its Phase 3 trial, causing the stock to plummet ~90% and trade near book value. The company's decision to discontinue other simufilam trials ...